Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells
Authors
Keywords
-
Journal
Pituitary
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-27
DOI
10.1007/s11102-018-0926-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Consensus Statement on acromegaly therapeutic outcomes
- (2018) Shlomo Melmed et al. Nature Reviews Endocrinology
- International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
- (2018) Thomas Günther et al. PHARMACOLOGICAL REVIEWS
- In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas
- (2017) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future
- (2016) Kjell Öberg et al. ENDOCRINE-RELATED CANCER
- Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cellsin vitro
- (2016) Alejandro Ibáñez-Costa et al. JOURNAL OF ENDOCRINOLOGY
- Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas
- (2016) Anat Ben-Shlomo et al. Pituitary
- Pasireotide: a novel treatment for patients with acromegaly
- (2016) Maria Fleseriu et al. Drug Design Development and Therapy
- The Treatment of Cushing's Disease
- (2015) Rosario Pivonello et al. ENDOCRINE REVIEWS
- The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease
- (2015) K. Hayashi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study
- (2015) Donato Iacovazzo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A Structural and Functional Acromegaly Classification
- (2015) Daniel Cuevas-Ramos et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Filamin A (FLNA) Plays an Essential Role in Somatostatin Receptor 2 (SST2) Signaling and Stabilization After Agonist Stimulation in Human and Rat Somatotroph Tumor Cells
- (2014) E. Peverelli et al. ENDOCRINOLOGY
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin receptor ligands and resistance to treatment in pituitary adenomas
- (2014) Daniel Cuevas-Ramos et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo
- (2014) Shingo Murasawa et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Carboxyl-terminal multi-site phosphorylation regulates internalization and desensitization of the human sst2 somatostatin receptor
- (2014) Andreas Lehmann et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- β-Arrestin 1 and 2 and G Protein-Coupled Receptor Kinase 2 Expression in Pituitary Adenomas: Role in the Regulation of Response to Somatostatin Analogue Treatment in Patients With Acromegaly
- (2013) Federico Gatto et al. ENDOCRINOLOGY
- Somatostatin receptors: From signaling to clinical practice
- (2013) Marily Theodoropoulou et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Preoperative Normalization of Cortisol Levels in Cushing's Disease After Medical Treatment: Consequences for Somatostatin and Dopamine Receptor Subtype Expression and In Vitro Response to Somatostatin Analogs and Dopamine Agonists
- (2013) R. van der Pas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide
- (2013) Olivera Casar-Borota et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Medical Treatment of Cushing's Disease
- (2013) Richard A. Feelders et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly
- (2012) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
- (2012) Annamaria Colao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucocorticoids regulate arrestin gene expression and redirect the signaling profile of G protein-coupled receptors
- (2012) R. H. Oakley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of somatostatin and dopamine D2 receptors in endocrine tumors
- (2011) Federico Gatto et al. ENDOCRINE-RELATED CANCER
- Ligand-Dependent Mechanisms of sst2A Receptor Trafficking: Role of Site-Specific Phosphorylation and Receptor Activation in the Actions of Biased Somatostatin Agonists
- (2011) Yachu J. Kao et al. MOLECULAR ENDOCRINOLOGY
- Effect of SOM230 (Pasireotide) on Corticotropic Cells: Action in Dogs with Cushing’s Disease
- (2011) Victor Castillo et al. NEUROENDOCRINOLOGY
- Pasireotide and Octreotide Stimulate Distinct Patterns of sst2ASomatostatin Receptor Phosphorylation
- (2010) Florian Pöll et al. MOLECULAR ENDOCRINOLOGY
- Pituitary somatostatin receptor signaling
- (2010) Anat Ben-Shlomo et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
- (2009) Anat Ben-Shlomo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification and Characterization of Two Novel Truncated but Functional Isoforms of the Somatostatin Receptor Subtype 5 Differentially Present in Pituitary Tumors
- (2009) Mario Durán-Prado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The clinical–molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology
- (2009) Diego Ferone et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Agonist-Biased Signaling at the sst2A Receptor: The Multi-Somatostatin Analogs KE108 and SOM230 Activate and Antagonize Distinct Signaling Pathways
- (2009) Renzo Cescato et al. MOLECULAR ENDOCRINOLOGY
- Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Traffickingin Vitro
- (2008) Sarah Lesche et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro
- (2008) C de Bruin et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Somatostatin agonists for treatment of acromegaly
- (2007) Anat Ben-Shlomo et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started